Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection

Journal of Leukocyte Biology

Volumn 94, Issue 4, 2013, Pages 835-843

  Kim, Sohn G ^a   Jung, James B ^a   Dixit, Dhaval ^a   Rovner Jr , Robert ^a   Zack, Jerome A ^a   Baldwin, Gayle C ^a   Vatakis, Dimitrios N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 and D4 receptors; Human immunodeficiency virus; Life cycle; Reservoir; Stimulant abuse

Indexed keywords

COCAINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; PRIORITY JOURNAL; T LYMPHOCYTE;

Σ1 AND D4 RECEPTORS; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; RESERVOIR; STIMULANT ABUSE;

COCAINE; HIV; HIV INFECTIONS; HUMANS; KINETICS; PHENOTYPE; RECEPTORS, DOPAMINE D4; RECEPTORS, SIGMA; REVERSE TRANSCRIPTION; RNA, MESSENGER; T-LYMPHOCYTES; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84884854203     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1112566     Document Type: Article

References (40)

1. Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., Chen, I. S. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222.
2. Vatakis, D. N., Bristol, G., Wilkinson, T. A., Chow, S. A., Zack, J. A. (2007) Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J. Virol. 81, 3574-3582.
3. Swiggard, W. J., O'Doherty, U., McGain, D., Jeyakumar, D., Malim, M. H. (2004) Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded. AIDS Res. Hum. Retroviruses 20, 285-295.
4. Zhou, Y., Zhang, H., Siliciano, J. D., Siliciano, R. F. (2005) Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 79, 2199-2210.
5. Cole, S. W., Jamieson, B. D., Zack, J. A. (1999) cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 162, 1392-1400.
6. Korin, Y. D., Zack, J. A. (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168.
7. Oswald-Richter, K., Grill, S. M., Leelawong, M., Unutmaz, D. (2004) HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. Eur. J. Immunol. 34, 1705-1714.
8. Saleh, S., Solomon, A., Wightman, F., Xhilaga, M., Cameron, P. U., Lewin, S. R. (2007) CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110, 4161-4164.
9. Unutmaz, D., KewalRamani, V. N., Marmon, S., Littman, D. R. (1999) Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189, 1735-1746.
10. Vatakis, D. N., Nixon, C. C., Bristol, G., Zack, J. A. (2009) Differentially stimulated CD4+ T cells display altered human immunodeficiency virus infection kinetics: implications for the efficacy of antiviral agents. J. Virol. 83, 3374-3378.
11. Cole, S. W., Korin, Y. D., Fahey, J. L., Zack, J. A. (1998) Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161, 610-616.
12. Baldwin, G. C., Roth, M. D., Tashkin, D. P. (1998) Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J. Neuroimmunol. 83, 133-138.
13. Delafuente, J. C., DeVane, C. L. (1991) Immunologic effects of cocaine and related alkaloids. Immunopharmacol. Immunotoxicol. 13, 11-23.
14. Di Francesco, P., Falchetti, R., Gaziano, R., Lanzilli, G., Casalinuovo, I. A., Ravagnan, G., Garaci, E. (1999) Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells. Clin. Exp. Immunol. 118, 428-434.
15. Di Francesco, P., Marini, S., Pica, F., Favalli, C., Tubaro, E., Garaci, E. (1992) In vivo cocaine administration influences lymphokine production and humoral immune response. Immunol. Res. 11, 74-79.
16. Gekker, G., Hu, S., Sheng, W. S., Rock, R. B., Lokensgard, J. R., Peterson, P. K. (2006) Cocaine-induced HIV-1 expression in microglia involves σ-1 receptors and transforming growth factor-β1. Int. Immunopharmacol. 6, 1029-1033.
17. Mao, J. T., Huang, M., Wang, J., Sharma, S., Tashkin, D. P., Dubinett, S. M. (1996) Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-γ production. Cell. Immunol. 172, 217-223.
18. Nair, M. P., Chadha, K. C., Hewitt, R. G., Mahajan, S., Sweet, A., Schwartz, S. A. (2000) Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin. Diagn. Lab. Immunol. 7, 96-100.
19. Nair, M. P., Mahajan, S. D., Schwartz, S. A., Reynolds, J., Whitney, R., Bernstein, Z., Chawda, R. P., Sykes, D., Hewitt, R., Hsiao, C. B. (2005) Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J. Immunol. 174, 6617-6626.
20. Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Molitor, T. W., Balfour H. H., Jr., (1991) Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-β. J. Immunol. 146, 81-84.
21. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, B. D., Zack, J. A., Baldwin, G. C. (2002) Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J. Infect. Dis. 185, 701-705.
22. Roth, M. D., Whittaker, K. M., Choi, R., Tashkin, D. P., Baldwin, G. C. (2005) Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J. Leukoc. Biol. 78, 1198-1203.
23. Bagasra, O., Pomerantz, R. J. (1993) Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J. Infect. Dis. 168, 1157-1164.
24. Carrico, A. W., Johnson, M. O., Morin, S. F., Remien, R. H., Riley, E. D., Hecht, F. M., Fuchs, D. (2008) Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on antiretroviral therapy. Brain Behav. Immun. 22, 1257-1262.
25. Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Verhoef, J., Edelman, C. K., Erice, A., Balfour H. H., Jr., (1992) Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J. Immunol. 149, 676-680.
26. Kapadia, F., Vlahov, D., Donahoe, R. M., Friedland, G. (2005) The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin. Infect. Dis. 41, 1027-1034.
27. Cook, J. A., Burke-Miller, J. K., Cohen, M. H., Cook, R. L., Vlahov, D., Wilson, T. E., Golub, E. T., Schwartz, R. M., Howard, A. A., Ponath, C., Plankey, M. W., Levine, A., Grey, D. D. (2008) Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22, 1355-1363.
28. Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, B., Campa, A. (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J. Acquir. Immune Defic. Syndr. 50, 93-99.
29. Baldwin, G. C., Tashkin, D. P., Buckley, D. M., Park, A. N., Dubinett, S. M., Roth, M. D. (1997) Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 156, 1606-1613.
30. Dhillon, N. K., Williams, R., Peng, F., Tsai, Y. J., Dhillon, S., Nicolay, B., Gadgil, M., Kumar, A., Buch, S. J. (2007) Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J. Neurovirol. 13, 483-495.
31. Guitart, X., Codony, X., Monroy, X. (2004) σ Receptors: biology and therapeutic potential. Psychopharmacology (Berl.) 174, 301-319.
32. Korin, Y., Zack, J. A. (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168.
33. Mao, J. T., Zhu, L. X., Sharma, S., Chen, K., Huang, M., Santiago, S. J., Gulsurd, J., Tashkin, D. P., Dubinett, S. M. (1997) Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-β. Cell. Immunol. 181, 38-43.
34. + T cells. J. Virol. 83, 6222-6233.
35. Bukrinsky, M. I., Sharova, N., Dempsey, M. P., Stanwick, T. L., Bukrinskaya, A. G., Haggerty, S., Stevenson, M. (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89, 6580-6584.
36. Al-Mawsawi, L. Q., Neamati, N. (2007) Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol. Sci. 28, 526-535.
37. Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M. R., Ghattas, G., Brenchley, J. M., Schacker, T. W., Hill, B. J., Douek, D. C., Routy, J. P., Haddad, E. K., Sekaly, R. P. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med, 15, 893-900.
38. Nishimura, Y., Sadjadpour, R., Mattapallil, J. J., Igarashi, T., Lee, W., Buckler-White, A., Roederer, M., Chun, T. W., Martin, M. A. (2009) High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections. Proc. Natl. Acad. Sci. USA 106, 8015-8020.
39. Neve, K. A., Seamans, J. K., Trantham-Davidson, H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165-205.
40. Zack, J. A., Kim, S. G., Vatakis, D. N. (2013) HIV restriction in quiescent CD4(+) T cells. Retrovirology 10, 37.